Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:36 pm Purchase |
2025-03-31 | 13G | Pasithea Therapeutics Corp. KTTA |
Armistice Capital, LLC | 142,082 4.990% |
8,295 (+6.20%) |
Filing History |
| 2025-05-12 4:08 pm Purchase |
2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA |
Mitchell P. Kopin | 317,863 4.990% |
317,863 (New Position) |
Filing History |
| 2025-05-12 10:07 am Purchase |
2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA |
CVI Investments, Inc. | 627,319 9.900% |
627,319 (New Position) |
Filing History |
| 2025-05-09 4:36 pm Sale |
2025-05-07 | 13G | Pasithea Therapeutics Corp. KTTA |
Orca Capital AG | 362,857 4.900% |
-8,285 (-2.23%) |
Filing History |
| 2025-05-09 4:31 pm Purchase |
2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA |
Orca Capital AG | 371,142 5.700% |
371,142 (New Position) |
Filing History |
| 2025-03-06 9:55 pm Purchase |
2025-03-01 | 13D | Pasithea Therapeutics Corp. KTTA |
Lawrence Steinman | 83,858 3.100% |
83,858 (New Position) |
Filing History |
| 2025-02-14 5:50 pm Purchase |
2024-12-31 | 13G | Pasithea Therapeutics Corp. KTTA |
Armistice Capital, LLC | 133,787 9.990% |
17,907 (+15.45%) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | Pasithea Therapeutics Corp. KTTA |
Armistice Capital, LLC | 115,880 9.990% |
115,880 (New Position) |
Filing History |
| 2023-06-07 6:29 pm Purchase |
2023-06-02 | 13D | Pasithea Therapeutics Corp. KTTA |
Lawrence Steinman | 78,859 6.000% |
78,859 (New Position) |
Filing History |
| 2023-02-14 6:28 pm Unchanged |
2022-10-22 | 13G | Pasithea Therapeutics Corp. KTTA |
Paul B Manning | 170,435 11.300% |
0 (Unchanged) |
Filing History |
| 2023-01-13 08:02 am Sale |
2022-12-31 | 13G | Pasithea Therapeutics Corp. KTTA |
Khire Uday | 61,405 4.600% |
-12,228 (-16.61%) |
Filing History |
| 2023-01-10 3:55 pm Sale |
2023-01-10 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 0 0.000% |
-89,421 (Position Closed) |
Filing History |
| 2022-12-13 7:26 pm Unchanged |
2022-12-09 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 89,421 6.100% |
0 (Unchanged) |
Filing History |
| 2022-11-01 5:28 pm Purchase |
2022-10-31 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 89,421 6.700% |
4,305 (+5.06%) |
Filing History |
| 2022-10-20 11:11 am Purchase |
2022-10-11 | 13G | Pasithea Therapeutics Corp. KTTA |
Khire Uday | 73,633 5.000% |
73,633 (New Position) |
Filing History |
| 2022-09-06 4:10 pm Purchase |
2022-09-02 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 85,116 6.400% |
3,358 (+4.11%) |
Filing History |
| 2022-09-01 06:05 am Purchase |
2022-08-19 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 81,758 6.100% |
8,980 (+12.34%) |
Filing History |
| 2022-08-11 10:26 am Purchase |
2022-08-09 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 72,778 5.500% |
14,441 (+24.75%) |
Filing History |
| 2022-07-27 9:45 pm Purchase |
2022-07-27 | 13D | Pasithea Therapeutics Corp. KTTA |
Camac Fund LP | 58,337 4.400% |
6,602 (+12.76%) |
Filing History |
| 2022-06-29 4:30 pm Purchase |
2022-06-22 | 13G | Pasithea Therapeutics Corp. KTTA |
Paul B Manning | 170,435 9.800% |
170,435 (New Position) |
Filing History |